Publications by authors named "F Rudilla Salvador"
Introduction: Elacestrant has shown significantly prolonged progression-free survival compared to standard-of-care endocrine therapy in estrogen receptor-positive (ER-positive), HER2-negative metastatic breast cancer (BC), while potential benefit in early-stage disease requires further exploration. The SOLTI-ELIPSE window-of-opportunity trial investigated the biological changes induced by a short course of preoperative elacestrant in postmenopausal women with early BC.
Methods: Eligible patients with untreated T1c (≥1.
Introduction: The prognostic value of PAM50 intrinsic subtypes (IS), cell cycle, and immune-related gene expression in HR+ /HER2- advanced breast cancer (BC) treated with CDK4/6 inhibitors (CDK4/6i) and endocrine therapy (ET) in a first-line metastatic setting is unclear. This study evaluates these biomarkers in metastatic biopsies from patients diagnosed with HR+ /HER2- advanced BC.
Methods: CDK-PREDICT study is a multicentric, ambispective observational cohort study conducted in six Spanish hospitals.
Article Synopsis
- Behçet's disease (BD) is a multisystem inflammatory condition that can impact the nervous system, sometimes referred to as neuro-Behçet.
- A 46-year-old woman with a history of BD was admitted for severe neck pain and neurological symptoms, leading to a brain MRI that indicated a possible diagnosis of neuro-Behçet.
- The patient was treated with corticosteroids and azathioprine, resulting in significant clinical improvement and resolution of the brain lesion, underscoring the need for precise diagnosis and timely treatment.